interferons: a promising potential therapy for mpn
Published 7 years ago • 590 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:25
interferons in the treatment of mpns: clinical trials in 2021
-
1:27
the use of interferons in the treatment of mpns
-
1:10
the treatment schedule for interferon therapy in patients with pv
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
0:48
promising therapeutic targets in mpns
-
1:44
the role of interferon in the treatment of accelerated/blast phase mpn
-
3:09
pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
3:40
recommendations for physicians treating pv: selecting between hydroxyurea and interferon
-
1:43
factors predicting durable remission after ifn therapy discontinuation in mpn patients
-
1:54
the potential role of cellular therapies and vaccines in the future treatment of mpns
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:29
changing attitudes to using interferon in pediatric patients with mpns
-
1:14
an overview of the current and future treatment landscape for mpns
-
2:50
insights into the ca057-003 trial: mezigdomide, tazemetostat & dexamethasone for r/r myeloma
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:31
emerging treatment options for patients with esa-refractory mds: luspatercept & imetelstat